The effects of anaesthetics on cisplatinum-induced toxicity at normal temperatures and during whole-body hyperthermia: the influence of NaCl concentration of the vehicle.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  International Journal of Hyperthermia

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3109/02656738809012403PMID 3171259
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum(II) and whole-body hyperthermia

  2004cited by this paper
• Effect of cis-diamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury.

  1988cited by this paper
• Acute systemic toxicity of combined cis-diamminedichloroplatinum and hyperthermia in the rat.

  1987cited by this paper
• The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats.

  1987cited by this paper
• Effect of hyperthermia on cisplatin pharmacokinetics in normal dogs.

  1986cited by this paper
• Timing of combined hyperthermia and 1,3-bis(2-chloroethyl)-1-nitrosourea or cis-diamminedichloroplatinum in BD IX rats with BT4A tumours.

  1985cited by this paper
• Combined hyperthermia and cis-diamminedichloroplatinum in BD IX rats with transplanted BT4A tumours.

  1985cited by this paper
• An update on the anticancer effects of a combination of chemotherapy and hyperthermia.

  1984cited by this paper
• General anesthesia for whole-body hyperthermia.

  1984cited by this paper
• Improvement in the therapeutic index of cisplatin (NSC 119875) by pharmacologically induced chloruresis in the rat.

  1983cited by this paper
• Whole-body hyperthermia and chemotherapy for treatment of patients with advanced, refractory malignancies.

  1982cited by this paper
• Whole-body hyperthermia and chemotherapy for treatment of patients with advanced, refractory malignancies

  1982cited by this paper
• The influence of misonidazole on the radiation response of murine tumors of different size: possible artifacts caused by pentobarbital sodium anesthesia.

  1981cited by this paper
• Comparison of the iv and ip routes of administration of cisplatin in dogs.

  1981cited by this paper
• Alterations in the toxicity of cis-dichlorodiammineplatinum-II and in tissue localization of platinum as a function of NaCl concentration in the vehicle of administration.

  1981cited by this paper
• Therapeutic synergism of hyperthermia-cis-platinum in a mouse tumor model.

  1980cited by this paper
• Nephrotoxicity of cis-dichlorodiammineplatinum(II).

  1979cited by this paper
• Nephrotoxicity of cis-dichlorodiammineplatinum(II).

  1979cited by this paper
• The effect of anesthetics on the radiosensitivity of a murine tumor.

  1979cited by this paper
• The effect of pentobarbital anaesthesia on the radiosensitivity of four mouse tumours.

  1979cited by this paper
• Pharmacokinetic study of cis-dichlorodiammineplatinum(II) (DDP) in the beagle dog: thermodynamic and kinetic behavior of DDP in a biologic millieu.

  1979cited by this paper
• Measurement of mammary tumor blood flow in unanesthetized rats.

  1978cited by this paper
• Radioprotection by pentobarbitone sodium of a murine tumour in vivo.

  1977cited by this paper
• Improvement of Cis‐dichlorodiammineplatinum (NSC 119875): Therapeutic index in an animal model

  1977cited by this paper
• Differences in the effects of anaesthesia on hypoxia in normal tissues.

  1977cited by this paper
• The radioprotective action on bone marrow CFU during immobilization of mice.

  1976cited by this paper
• The effect of anaesthetics on blood perfusion in transplanted mouse tumours.

  1975cited by this paper
• Acute toxicologic and pathologic effects of cis-diamminedichloroplatinum (NSC-119875) in the male rat.

  1971cited by this paper
• Acute toxicologic and pathologic effects of cis-diamminedichloroplatinum (NSC-119875) in the male rat.

  1971cited by this paper
• Platinum Compounds: a New Class of Potent Antitumour Agents

  1969cited by this paper
• Some effects of pentobarbital anesthesia on renal hemodynamics, water and electrolyte excretion in the dog.

  1957cited by this paper
• Veterinary Pharmacology and Therapeutics

  1885cited by this paper

• Cisplatin, a platinum-containing antineoplastic drug: perspectives on analytical chemistry and prevention of ototoxicity

  2010cites this paper
• The importance of schedule in whole body thermochemotherapy

  2008cites this paper
• The effect of whole-body hyperthermia combined with 'metronomic' chemotherapy on rat mammary adenocarcinoma metastases

  2003cites this paper
• Cisplatin toxicity in the rat may be influenced by anaesthetic agents.

  2000cites this paper
• Comparison of the effects of two different whole body hyperthermia protocols on the distribution of murine leukocyte populations

  2000cites this paper
• Therapeutic efficacy and apoptosis and necrosis kinetics of doxorubicin compared with cisplatin, combined with whole‐body hyperthermia in a rat mammary adenocarcinoma

  1998cites this paper
• Long-duration, mild whole body hyperthermia with cisplatin: tumour response and kinetics of apoptosis and necrosis in a metastatic rat mammary adenocarcinoma.

  1997cites this paper
• Optimal duration of whole body hyperthermia when combined with cis-diaminne-1,1-cychlobutane dicarboxylate platinum (II) (carboplatin).

  1997cites this paper
• Clinical Practice of Whole-Body Hyperthermia: New Directions

  1996cites this paper
• Protective effect of NG-monomethyl-L-arginine against hypotension inducted by combined tumour necrosis factor-alpha and whole body hyperthermia in rats.

  1996cites this paper
• Whole-body hyperthermia and lonidamine as adjuvant therapy to treatment with cisplatin with or without local radiation in mouse bearing the Lewis lung carcinoma.

  1995cites this paper
• Effects of anesthetics on ormaplatin biotransformations in the Fischer 344 rat.

  1995cites this paper
• Chronic effect of whole-body hyperthermia combined simultaneously with cis-diamminedichloroplatinum (II) on normal tissue in rat.

  1995cites this paper
• Apoptosis in tumors and normal tissues induced by whole body hyperthermia in rats.

  1995cites this paper
• Effects of anesthetics on qrmaplatin biotransformations in the fischer 344 rat

  1995cites this paper
• Therapeutic efficacy of long duration-low temperature whole body hyperthermia when combined with tumor necrosis factor and carboplatin in rats.

  1994cites this paper
• Effect of whole body hyperthermia on cis-diamminedichloroplatinum (II)-induced antitumour activity and tissue Pt-distribution: do anaesthetics influence the therapeutic ratio?

  1993cites this paper
• Kidney trace metal response to combined cisplatin (CDDP) and hyperthermia.

  1993cites this paper
• Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats.

  1993cites this paper
• Whole Body Hyperthermia: Biological and Clinical Aspects

  1992cites this paper
• Increased therapeutic efficacy induced by tumor necrosis factor alpha combined with platinum complexes and whole-body hyperthermia in rats.

  1992cites this paper
• Chemotherapy resistant sarcoma treated with whole body hyperthermia (WBH) combined with 1-3-bis(2-chloroethyl)-1-nitrosourea (BCNU).

  1992cites this paper
• Whole-body hyperthermia as an adjuvant to treatment with platinum complexes with or without etanidazole in mice bearing the Lewis lung carcinoma or the FSaLL fibrosarcoma.

  1992cites this paper
• Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats.

  1991cites this paper
• Protective effect of ICRF-187 against normal tissue injury induced by adriamycin in combination with whole body hyperthermia.

  1991cites this paper
• Effect of adriamycin combined with whole body hyperthermia on tumor and normal tissues.

  1991cites this paper
• Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in rats.

  1991cites this paper
• Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiation.

  1991cites this paper
• Biological Basis of Thermotherapy (With Special Reference to Oncology)

  1990cites this paper
• Increased therapeutic gain of combined cis-diamminedichloroplatinum (II) and whole body hyperthermia therapy by optimal heat/drug scheduling.

  1989cites this paper
• A comparison of thermal enhancement of cis-diamminedichloroplatinum (II) induced renal and intestinal toxicities by whole body hyperthermia in the rat.

  1989cites this paper